Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940-1999): Temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients

World Journal of Surgery

Volumn 26, Issue 8, 2002, Pages 879-885

  Hay, Ian D ^a   Thompson, Geoffrey B ^a   Grant, Clive S ^a   Bergstralh, Eric J ^a   Dvorak, Catherine E ^a   Gorman, Colum A ^a   Maurer, Megan S ^a   McIver, Bryan ^a   Mullan, Brian P ^a   Oberg, Ann L ^a   Powell, Claudia C ^a   Van Heerden, Jon A ^a   Goellner, John R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; CHILD; CLINICAL FEATURE; CONFERENCE PAPER; FEMALE; HUMAN; LOBECTOMY; MAJOR CLINICAL STUDY; MALE; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY; TREATMENT OUTCOME; TUMOR RECURRENCE; ARTICLE; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PAPILLARY CARCINOMA; PRESCHOOL CHILD; RISK FACTOR; THYROID TUMOR; TIME;

RADIOACTIVE IODINE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RISK FACTORS; THYROID NEOPLASMS; THYROIDECTOMY; TIME FACTORS; TREATMENT OUTCOME;

EID: 0036691093     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-002-6612-1     Document Type: Conference Paper

References (31)

1. Grebe SKG, Hay ID. Follicular cell-derived thyroid carcinoma. Cancer Treat. Res. 1997;89:91-140
2. Hundahl SA, Fleming ID, Framgen AM, et al. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995. Cancer 1998;83:2638-2648
3. Ebihara S, Saikawa M. Survey and analysis of thyroid carcinoma by the Japanese Society of Thyroid Surgery. Thyroidol. Clin. Exp. 1998;10:85-91
4. Beahrs OH, Woolner LB. The treatment of papillary carcinoma of the thyroid gland. Surg. Gynecol. Obstet. 1959;108:43-48
5. Grebe SKG, Hay ID. The role of surgery in the management of differentiated thyroid cancer. J. Endocrinol. Invest. 1997;20:32-35
6. Hay ID, Grant CS, Bergstralh EJ, et al. Unilateral total lobectomy: Is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? Surgery 1998;124:958-966
7. Hay ID. Papillary thyroid carcinoma. Endocrinol. Metab. Clin. North Am. 1990;19:545-576
8. Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am. J. Med. 1994;97:418-428
9. Singer P, Cooper DS, Daniels GH. Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. Arch. Intern. Med. 1996;156:2165-2172
10. Hay ID, Feld S, Garcia M. AACE clinical practice guidelines for the management of thyroid carcinoma. Endocr. Pract. 1997;3:60-71
11. Shaha AR, Byers RM, Terz JJ. Thyroid cancer surgical practice guidelines: scope and format of guidelines. Oncology 1997;11:1228-1234
12. Thyroid Carcinoma Task Force. AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. Endocr. Pract. 2001;7:202-221
13. Mazzaferri EL. NCCN thyroid carcinoma practice guidelines. Oncology 1999;13:391-416
14. Mazzaferri EL. Long-term outcome of patients with differentiated thyroid carcinoma: effect of therapy. Endocr. Pract. 2000;6:467-472
15. Mazzaferri EL, Kloos RT. Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J. Clin. Endocrinol. Metab. 2001;86:1467-1473
16. Cady B. Our AMES is true: how an old concept still hits the mark: or, risk group assignment points the arrow to rational therapy selection in differentiated thyroid cancer. Am. J. Surg. 1997;174:462-468
17. Balfour DC. Cancer of the thyroid gland. Med. Rec. 1918;94:846-852
18. Woolner LB, Beahrs OH, Black BM, et al. Thyroid carcinoma: general considerations and follow-up data on 1181 cases. In Young S, Inman DR, editors, Thyroid Neoplasia, London, Academic Press, 1968;51-79
19. McConahey WM, Hay ID, Woolner LB, et al. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin. Proc. 1986;61:978-996
20. Hay ID, Grant CS, van Heerden JA, et al. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery 1992;112:1139-1147
21. Hedinger C, Williams ED, Sobin LH. Histological typing of thyroid tumours. In: International Histological Classification of Tumours: World Health Organization, 2nd edition, New York, Springer-Verlag, 1988
22. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J. Am. Stat. Assoc. 1958;53:457-481
23. Peto R, Peto J. Asymptotically efficient rank invariant procedures (with discussion). J. R. Stat. Soc. A 1972;135:185-198
24. SAS Institute. SAS/STAT User's Guide, Version 6 edition, Cary, NC, SAS Institute, 1990
25. Sobin LH, Wittekind CH. TNM Classification of Malignant Tumours, International Union Against Cancer, 5th edition, New York, Wiley-Liss, 1997
26. Hay ID, Bergstralh EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1,779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993;114:1050-1058
27. Sutton RT, Reading CC, Charboneau JW, et al. Ultrasonographic-guided biopsy of neck masses in the postoperative assessment of patients with thyroid malignancy. Radiology 1988;168:769-773
28. Wang W, Macapinlac H, Larson SM. F-18-2-fluoro-2-deoxy-D-glucose positron emission tomography localized residual thyroid cancer in patients with negative diagnostic 1-131 whole body scans and elevated serum thyroglobulin levels. J. Clin. Endocrinol. Metab. 1999;84:2291-2302
29. 131I scanning. J Clin. Endocrinol. Metab. 2002;87:1486-1489
30. DeGroot LJ. Long-term impact of initial and surgical therapy on papillary and follicular thyroid cancer [editorial]. Am. J. Med. 1994;97:499-500
31. Sisson JC. Applying the radioactive eraser: 1-131 to ablate normal thyroid tissue in patients from whom thyroid cancer has been resected. J. Nucl. Med. 1983;24:743-745